On August 21, 2018, the Company entered into a joint agreement to acquire 51% controlling interest of The Asher Houses’ Pet CBD line for $1,200,000 worth of common shares to be vested over a 12-month period. The Company issued total of 585,368 shares of its common stock valued at $1,200,000 for the acquisition of The Asher Houses’ Pet CBD Line entered on August 21, 2018 and completed the acquisition in the quarter ended June 30, 2019. On June 30, 2020, we entered into an agreement with Lee Asher and the Asher House™ to terminate the consulting agreement with Lee Asher. Pursuant to the termination agreement, the Company transferred its 51% interest in TAH II, LLC to Lee Asher, and agreed to pay a $5,000 final consulting fee. The parties agreed to sell off remaining inventory with the Company received 30% gross proceeds from the sales. The parties agreed to a mutual release of all claims. As of June 30, 2020, the Company and TAH II, LLC terminated the agreement.